KalVista appoints Brian Piekos as CFO effective Sept 9; 100K stock option inducement granted

KalVista Pharmaceuticals, Inc.

Brian Piekos joins as CFO; previously CFO of Elicio Therapeutics and Gemini Therapeutics.
Piekos receives $460K base salary, 40% bonus target, and 100K stock options at $11.87 with 4-year vest.
Employment agreements for CEO Ben Palleiko and CMO Paul Audhya amended (severance, Section 280G updates).
KalVista highlights Piekos' experience as it prepares for sebetralstat commercialization.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Brian Piekos

Chief Financial Officer

KALV · KalVista Pharmaceuticals, Inc.

Effective: 2024-09-09
Filed: September 10, 2024, 7:59 PM ET

Effective September 9, 2024, the Board of Directors (the “Board”) of KalVista Pharmaceuticals, Inc. (the “Company”) appointed Brian Piekos as the Company’s Chief Financial Officer, principal financial officer and principal accounting officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brian Piekos was appointed as Chief Financial Officer at KalVista Pharmaceuticals, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

Effective September 9, 2024, the Board of Directors (the “Board”) of KalVista Pharmaceuticals, Inc. (the “Company”) appointed Brian Piekos as the Company’s Chief Financial Officer, principal financial officer and principal accounting officer.

View on SEC.gov

KalVista Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-105182

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.